Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies
Xidi Wang, Miao Zhou, Yu Liu, et al.
Cancer Letters (2023) Vol. 561, pp. 216157-216157
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Yumin Wang, Yongming Chen, Junjing Zhang, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101018-101018
Open Access | Times Cited: 76
Copper homeostasis and cuproptosis in cardiovascular disease therapeutics
Lifang Yang, Pingping Yang, Gregory Y.H. Lip, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 9, pp. 573-585
Closed Access | Times Cited: 55
The copper age in cancer treatment: From copper metabolism to cuproptosis
Wensheng Xie, Zhenhu Guo, Lingyun Zhao, et al.
Progress in Materials Science (2023) Vol. 138, pp. 101145-101145
Closed Access | Times Cited: 41
Copper homeostasis and cuproptosis in cancer immunity and therapy
Wei‐Qing Liu, Wanrong Lin, Yan Li, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 211-227
Open Access | Times Cited: 41
Comprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes
Shu-Rui Li, Yi-Min Tan, Ling Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1348-1348
Open Access | Times Cited: 38
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 37
Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases
Xiao-xia Ban, Hao Wan, Xin-xing Wan, et al.
Current Medical Science (2024) Vol. 44, Iss. 1, pp. 28-50
Open Access | Times Cited: 20
Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights
K.M. Abdullah, Jyoti Kaushal, Simran Takkar, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27496-e27496
Open Access | Times Cited: 14
Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
MOF/MXene-loaded PVA/chitosan hydrogel with antimicrobial effect and wound healing promotion under electrical stimulation and improved mechanical properties
Nan Zhang, Xiuwen Zhang, Yueyuan Zhu, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130625-130625
Closed Access | Times Cited: 13
Unveiling the potential of HKUST-1: synthesis, activation, advantages and biomedical applications
Liuxuan Yang, Ke Wang, Ling Guo, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 11, pp. 2670-2690
Closed Access | Times Cited: 12
Optimizing Therapeutics for Intratumoral Cancer Treatments: Antiproliferative Vanadium Complexes in Glioblastoma
Angie Bates, Kameron L. Klugh, Anna O. Galaeva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 994-994
Open Access | Times Cited: 1
Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
Xuejia Kang, Sanika Jadhav, Manjusha Annaji, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1567-1567
Open Access | Times Cited: 23
Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies
Chenbin Bian, Zhuangzhuang Zheng, Jing Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex
Siyu Xu, Yashuai Hao, Xinyi Xu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7911-7920
Closed Access | Times Cited: 8
Mechanisms of cuproptosis and its relevance to distinct diseases
Qiao-mei Lou, Feifan Lai, Jingwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 981-1006
Closed Access | Times Cited: 8
Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives
Chenliang Zhang, Tingting Huang, Liping Li
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Zinc, copper, copper-to-zinc ratio, and other biometals in blood serum and tumor tissue of patients with colorectal cancer
Anatoly V. Skalny, Н. Е. Кушлинский, Tatiana V. Korobeinikova, et al.
BioMetals (2025)
Closed Access
Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease
Yun Mao, Huilan Chen, Weihan Zhu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 883-894
Open Access
Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials
Zixin Wu, Guishuai Lv, Fuxue Xing, et al.
Cancer Letters (2023) Vol. 571, pp. 216348-216348
Closed Access | Times Cited: 14
Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases
Zhibo Yang, Ridong Feng, Zhao Hai
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1330-1360
Closed Access | Times Cited: 5
Multi-omics analysis reveals cuproptosis and mitochondria-based signature for assessing prognosis and immune landscape in osteosarcoma
Chenguang Jia, Mei Liu, Li‐Ming Yao, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Adaptable Biomolecule-Interactive Dual Colorimetric Chemosensor for Cu2+ and Pd2+: Insight from Crystal Structure, Photophysical Investigations, Real-Time Sampling, and Molecular Logic Circuits
Subrata Mandal, Akash Das, Amitav Biswas, et al.
Crystal Growth & Design (2024) Vol. 24, Iss. 3, pp. 1051-1067
Closed Access | Times Cited: 4
Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer
Jiahao Wu, Tian-cheng Cheng, Bei Zhu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Cancer Letters (2024) Vol. 598, pp. 217102-217102
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top